GlycoMimetics Ownership | Who Owns GlycoMimetics?
GlycoMimetics Ownership Summary
GlycoMimetics is owned by 8.54% institutional investors, 2.86% insiders, and 88.60% retail investors. Bvf inc/il is the largest institutional shareholder, holding 14.80% of GLYC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in GlycoMimetics shares.
GLYC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | GlycoMimetics | 8.54% | 2.86% | 88.60% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bvf inc/il | 9.54M | 14.80% | $2.38M |
| Artal group | 8.59M | 13.33% | $2.42M |
| Logos global management lp | 5.40M | 8.37% | $1.34M |
| Adage capital partners gp | 5.09M | 7.90% | $1.27M |
| Vr adviser | 3.00M | 4.65% | $747.00K |
| Vanguard group | 2.67M | 4.14% | $664.88K |
| Wellington management group llp | 1.41M | 2.19% | $351.94K |
| Goldman sachs group | 804.34K | 1.25% | $226.50K |
| Blackrock funding, inc. /de | 728.64K | 1.13% | $181.43K |
| Blackrock | 723.18K | 1.12% | $203.65K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caxton | 203.58K | 0.31% | $50.90K |
| Logos global management lp | 5.40M | 0.16% | $1.34M |
| Bvf inc/il | 9.54M | 0.08% | $2.38M |
| Artal group | 8.59M | 0.06% | $2.42M |
| Vr adviser | 3.00M | 0.05% | $747.00K |
| Adar1 capital management | 331.83K | 0.02% | $82.63K |
| Ground swell capital | 33.23K | 0.01% | $8.27K |
| Intellectus partners | 45.97K | 0.00% | $11.45K |
| Adage capital partners gp | 5.09M | 0.00% | $1.27M |
| Xtx topco | 64.24K | 0.00% | $16.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Logos global management lp | 5.40M | 0.16% | 5.40M |
| Adage capital partners gp | 5.09M | 0.00% | 5.09M |
| Vr adviser | 3.00M | 0.05% | 3.00M |
| Wellington management group llp | 1.41M | 0.00% | 1.41M |
| Jefferies financial group | 423.78K | 0.00% | 423.78K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nea management company | - | - | -3.84M |
| Octagon capital advisors lp | - | - | -3.00M |
| Siren | - | - | -1.97M |
| Axa | - | - | -1.59M |
| Renaissance | 41.15K | - | -739.95K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Logos global management lp | 5.40M | 0.16% | 5.40M | $1.34M |
| Adage capital partners gp | 5.09M | 0.00% | 5.09M | $1.27M |
| Vr adviser | 3.00M | 0.05% | 3.00M | $747.00K |
| Wellington management group llp | 1.41M | 0.00% | 1.41M | $351.94K |
| Jefferies financial group | 423.78K | 0.00% | 423.78K | $105.52K |
Sold Out
| Holder | Change |
|---|---|
| Fmr | -67.00 |
| Wells fargo & company/mn | -383.00 |
| Old point trust & financial services n a | -500.00 |
| National bank of canada /fi/ | -600.00 |
| Qube research | -1.10K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 15 | -55.88% | 5,507,448 | -69.04% | 8 | 1.12% | 7 | -53.33% | 1 | -90.91% |
| Sep 30, 2024 | 33 | -19.51% | 17,775,290 | -30.46% | 27 | 1.75% | 14 | 16.67% | 11 | -38.89% |
| Jun 30, 2024 | 41 | -49.38% | 25,560,030 | -30.64% | 39 | 1.21% | 12 | -75.51% | 18 | 100.00% |
| Mar 31, 2024 | 81 | 32.79% | 36,848,906 | 4.98% | 57 | 1.92% | 49 | 81.48% | 9 | -35.71% |
| Dec 31, 2023 | 61 | 24.49% | 35,101,664 | 1.11% | 54 | 1.87% | 27 | 107.69% | 14 | -22.22% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.93M | 2.98% | - |
| Vanguard US Total Market Shares ETF | 1.93M | 2.98% | -1.00 |
| Wellington CIF Biotechnology | 1.22M | 1.89% | 1.22M |
| Vanguard Institutional Extnd Mkt Idx Tr | 730.60K | 1.13% | - |
| MEDICAL BioHealth EUR Acc | 609.48K | 0.95% | - |
| Fidelity Extended Market Index | 287.45K | 0.45% | -1.83K |
| iShares Micro-Cap ETF | 112.18K | 0.17% | - |
| BlackRock Extended Equity Market K | 107.17K | 0.17% | -46.00 |
| Extended Equity Market Fund K | 106.04K | 0.16% | 325.00 |
| Fidelity Total Market Index | 80.84K | 0.13% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 08, 2024 | Invus Public Equities, L.P. | - | Sell | $50.01K |
| Aug 07, 2024 | Invus Public Equities, L.P. | - | Sell | $11.20K |
| Aug 05, 2024 | Invus Public Equities, L.P. | - | Sell | $31.00K |
| Aug 06, 2024 | Invus Public Equities, L.P. | - | Sell | $10.19K |
| Aug 01, 2024 | Invus Public Equities, L.P. | - | Sell | $13.74K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 9 |
| 2024 Q2 | 3 | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | 2 | - |
GLYC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools